Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/319494
Type: Artigo de periódico
Title: 2-aryl-3-(2-morpholinoethyl)thiazolidin-4-ones: Synthesis, Anti-inflammatory In Vivo, Cytotoxicity In Vitro And Molecular Docking Studies
Abstract: Seven new 4-thiazolidinones bearing the morpholino moiety were easily synthesized by one-pot reactions of 4-(2-aminoethyl)morpholine (2-morpholinoethylamine), arenealdehydes and mercaptoacetic acid refluxing toluene for 19 h with moderate to good yields (45-97%). These novel compounds were fully identified and characterized by NMR spectroscopy and mass spectrometry. Thiazolidin-4-ones in vivo anti-inflammatory activities were determined using a croton oil-induced ear edema model of inflammation in BALB C mice. The best results were found for compounds 4c (49.20 mmol/kg), 4d (49.20 mmol/kg) and 4f (52.48 mmol/kg), which showed the ability to decrease the ear edema in mice by 50%, 48% and 54%, respectively, when compared to the standard drug indomethacin. In addition, the in vitro cytotoxicity activity of thiazolidin-4-ones against Vero cells was also performed and four compounds (4a, 4c, 4d and 4f) showed no toxic effect at 500 μg/mL. A docking simulation of compounds into the 1Q4G (COX-1) and 4PH9 (COX-2) enzymes binding site was conducted. This preliminary result will guide us in for further studies to improve the anti-inflammatory activity. © 2016 Elsevier Masson SAS. All rights reserved.
Editor: Elsevier Masson SAS
Citation: European Journal Of Medicinal Chemistry. Elsevier Masson Sas, v. 118, p. 259 - 265, 2016.
Rights: fechado
Identifier DOI: 10.1016/j.ejmech.2016.04.028
Address: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964810517&partnerID=40&md5=fb4dc34d05be7726afa3ffa1c9f1e7b6
Date Issue: 2016
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
2-s2.0-84964810517.pdf732.32 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.